Originally posted by TheRelapse
View Post
RiverBabe's Baby Biotechs
Collapse
X
-
THE SKIRACER'S EDGE: MAKE THE EDGE IN YOUR FAVOR
-
-
Hello TheRelapse!
Welcome to the forum! Sorry it took me so long to get back to you. I composed a neat message to you with charts and all, then promptly lost it while searching PBTH. Anyway, your first post was a good one. Looks like you know a lot about what you are doing! Look up "JohnHenry" in the Community. He is also young and good! To upload your avatar, go to User CP, avatar, click Custom and upload one of two ways. Also can do a Profile Picture by clicking on left menu appropriately. If you need help uploading charts to this forum, just ask us.
PBTH has broken out! Fantastic volume for last few days, and very bullish long-tailed hammer on the close. This is the daily, for anyone interested. They got a tremendous boost, probably due to a favorable report at the Jeffries Conference. I couldn't find it, but somebody knows something.
I was checking out the TEVA acquisition of Cogenesys from HGS when I lost this. Looks like the major technology is similar to Prolor's, adding a protein (albumin, a really HUGE protein compared to CTP, and potential immune response, BAD, if it's not human albumin) to the end of a drug to increase half-life in the body (i.e., a once-a-week dose instead of once-a-day, etc. http://blogs.wsj.com/health/2008/01/...bumin-rolling/ This link says this technology has changed hands (HGS to Novartis to Teva) a few times. Don't know much about it, but it appears TEVA wants to go generic with it eventually, so they are a PBTH competitor.
Honestly, I am not a fundamental analysis person. My eyes glaze over. So, I really can't answer the question about how this affects Teva's bottom line. Or Prolor's. I can say that if Prolor finds another partner like Merck, their pipeline will be well funded for adding their CTP to other drugs, and the list of possibilities is extensive. For now, it is still "development stage." Long term all of these stocks are high risk, but approval for sale product in Europe means the US probably won't be far behind. And, any partnership announcement will give another short term boost. 9? Can't say, but what the heck. Play a few sheckels and take your chances! Only IMHO of course. But this boost might only because of the Jeffries report. Don't let your short term profits now get away from you. This market is way too unpredictable. Take it, run, get back in on a pull back. I have seen too many of my profits dissolve in this market.
Takeover candidate? Maybe. A long wait? Possibly. Worth holding long for that purpose if you have those sheckels to spare for long term. You might be handsomely rewarded. (geez, I'm no help at all today.) River
Comment
-
-
Thanks a lot for the well researched reply.
I read that the teva acquisition of cogenyses would supplement teva's pipeline with some perscription drugs and not continue to limit them to generics. I don't think the fact that teva acquired the HGH from cogenyses necessarily means they will make it a generic.
I'm holding pbth into the open tomorrow and will make a decision to hold or sell when I see the trend at the open. This seems to be a good company and I will definitely be trying to buy again on a dip.
Comment
-
-
Relapse - PBTH
Relapse, looks like PBTH hit a triple top @ 8.34 in last two days. More resistance here. If it breaks it later, go for the ride. We're supposed to get a short term (be nimble) boost in the next few days, according to my favorite guru. But IMHO, I would take your short term gains now and buy again on the inevitable pull-back. This could be just the "Jeffries" blip.Last edited by riverbabe; 06-11-2010, 09:52 AM.
Comment
-
-
PBTH just went positive for the day and broke through the $8.34 resistance. Are you viewing this as a very positive sign heading into next week or do you still think a pullback is in order. I'm sure there will be a pullback, but after todays action I think it will be a bit higher. I may take profits at the close, not sure yet, still trying to analyze what today meant for this stock.
Comment
-
-
I'm really enjoying this thread, River. Technically, DNDN looks good right here at $40.59... I'd like to see it keep its head above the $40 markerHide not your talents.
They for use were made.
What's a sundial in the shade?
- Benjamin Franklin
Comment
-
-
Originally posted by peanuts View PostI'm really enjoying this thread, River. Technically, DNDN looks good right here at $40.59... I'd like to see it keep its head above the $40 marker
They keep filing SEC form 4s, I think the options holders among the insiders are cashing in. This keeps supply up and pps down. They have filed about 30 of these or more since the good news. (I get email notification). I'm waiting for that supply to slow down before the price heads higher.
Comment
-
-
River,
Have I got a stock for you! Not a biotech but just as good, deals in patents. This one has been popping up on my radar for months and I may have to buy it now. It is..............you ready? Uptrender ACTG. You'll like what you see with this one.
------------billy
Comment
-
-
Originally posted by billyjoe View PostRiver,
Have I got a stock for you! Not a biotech but just as good, deals in patents. This one has been popping up on my radar for months and I may have to buy it now. It is..............you ready? Uptrender ACTG. You'll like what you see with this one.
------------billy
Comment
-
-
Originally posted by billyjoe View PostRiver,
Call me crazy but I just bought 500 ACTG @14.73. The optimist in me will do me in yet.
-----------billy
Comment
-
-
Actg
Acacia Research Corporation (ACTG): Billy, looks like you have found a potential big winner here (but see BUT below). It is one cash cow company. Their officers make $324K-$474K per year plus stock options and bonuses, although that might only just cover what it costs to live in Newport Beach, CA.
These are their rather formidable profiles: http://people.forbes.com/profile/paul-r-ryan/641; http://people.forbes.com/profile/robert-l-harris/642; http://people.forbes.com/profile/clayton-j-haynes/634;
(This is the head patent guy, Dooyong Lee)http://www.law.northwestern.edu/news...m?eventid=1693
(This is the other patent guy, Edward J. Treska
BUT
Now, here is the bad part: They apparently have a subsidiary called "Global Patent Holdings" that is not-affectionately called a "patent troll". http://ipbiz.blogspot.com/2004/12/ac...of-global.html To tell more of their story, this link is to an exemplary experience with a particular patent (you have to scroll all the way down to the comments, and the last comment says it's "dead" -- finally). http://patentfizz.com/fizzdisplay.php?patno=5253341.
For a shorter version of this same story, see http://www.techdirt.com/blog.php?com...atent+holdings. (Disclosure: I know Greg Aharonian. He's the good guy who got sued for speaking his mind.)
Is this a good investment? Like I said, it is a cash cow and it takes risks post-patent that the inventors wouldn't be able to afford. When they win, they win big. When they lose, that's show-biz folks. See any and all the recent headlines at yahoo finance: http://finance.yahoo.com/q/h?s=ACTG+Headlines
Swallow hard, close at least one eye, and go for it billy!
Comment
-
Comment